dermatology-2017-scientifictracks-abstracts

17 / 19

Page 52
Notes:
conferenceseries.com
June 19-20, 2017 Philadelphia, USA
14th International Conference on
Clinical and Experimental Dermatology
Volume 8, Issue 4 (Suppl) J Clin Exp Dermatol Res, an open access journal
ISSN:2155-9554 Dermatology 2017
June 19-20, 2017
Erythema gyratum repens secondary to acute myeloblastic leukemia
Alexandre Malek1, Patric-Eric Nasnas2 and Roy Nasnas1
1Saint Joseph University, Lebanon
2Lebanese American University, Lebanon
An 80 year Caucasian man was admitted to the hospital for prolonged fever, weight loss and general status alteration. He
noted a pruritic skin lesion. As past medical history, he had been treated for Hodgkin lymphoma in 1994 and non-Hodgkin
lymphoma in 2004. An year ago, he developed myelodysplastic syndrome. Thoraco-abdominopelvic CT scan, gastroscopy and
colonoscopy were normal. PPD skin test was negative and pan cultures were sterile. The physical examination was normal
except the presence of multiple, annular, rapidly growing erythematous plaques over the right thigh. Bone marrow aspirate
and biopsy revealed acute myeloblastic leukemia (AML). Diagnosis of Erythema Gyratum Repens (EGR) was made on clinical
ground and it was secondary to AML. EGR in 80% of cases is related to underlying malignancies most notably lung cancer.
However, EGR in 20% is associated with non-neoplastic diseases such as pulmonary tuberculosis, autoimmune or connective
tissue conditions.
Biography
Alexandre Malek is a Medical Doctor graduated in 2012. He then did Internal Medicine and now he is in his last year of Infectious Disease Speciality. He did his
studies at Saint Joseph University, Faculty of Medicine, Beirut, Lebanon. Currently, he is doing one year internship in Infectious Disease in Paris, France.
Alexandre Malek et al., J Clin Exp Dermatol Res 2017, 8:4 (Suppl)
DOI: 10.4172/2155-9554-C1-059